Generation Bio

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Generation Bio and other ETFs, options, and stocks.

About GBIO

Generation Bio Co. is a genetic medicine company focused on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process. 

CEO
Cameron Geoffrey McDonough
CEOCameron Geoffrey McDonough
Employees
150
Employees150
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2016
Founded2016
Employees
150
Employees150

GBIO Key Statistics

Market cap
319.25M
Market cap319.25M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
197.15K
Average volume197.15K
High today
$5.43
High today$5.43
Low today
$5.11
Low today$5.11
Open price
$5.18
Open price$5.18
Volume
150.84K
Volume150.84K
52 Week high
$24.43
52 Week high$24.43
52 Week low
$3.96
52 Week low$3.96

Analyst ratings

71%

of 7 ratings
Buy
71.4%
Hold
28.6%
Sell
0%

GBIO Earnings

-$0.66
-$0.44
-$0.22
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, Pre-Market
ActualExpected Nov 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.